Because theyre low in fat, theyre a good option for patients taking GLP-1 medications
(69) demonstrated that 14-day exposure to a eucaloric very-low-carbohydrate ketogenic diet as adjuvant treatment to first-generation somatostatin receptor ligands decreased IGF-I without increasing GH levels in acromegaly patients
Since semaglutide has a 7-day half-life, injecting on day 5 would compound the medication and potentially lead to higher-than-intended concentrations, increasing nausea, vomiting, and gastrointestinal side effects
However, it is not a "standard" test included in a typical annual physical or a routine blood panel at a walk-in clinic
The FDA has not established a definitive causal link between GLP-1 medications and clinical depression as a primary safety signal
Research shows that low B12 levels are associated with obesity and being overweight